At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Evaluation of the Effect of a Vaginal Ring With Meloxicam on Primary Dysmenorrhea in Women of Childbearing Age
In Brief
A Phase 3 clinical trial evaluating Meloxicam, Diclofenac Potassium, and 2 other interventions for Dysmenorrhea. Completed, enrolled 68 participants across 1 site.
Detailed Summary
The investigators propose that the sustained administration of a vaginal ring would have a better response with respect to pain and a better safety profile than the oral administration of a non-steroidal anti-inflammatory drug. To assess the relief of the symptoms associated with dysmenorrhea, a specific survey was elaborated that also includes a Visual Analog Scale (VAS) to objectify and measure dysmenorrhea as is the case with McGill's Pain Questionnaire (MPQ).
Study Details
Timeline
Interventions
1 Meloxicam Vaginal Ring (MVR) for 4-6 days
1 tablet 50 mg diclofenac every 12 hours for 4-6 days
1 placebo tablet every 12 hours for 4-6 days
1 placebo vaginal ring for 4-6 days